Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,331 across all filing types
Latest filing 2022-11-02 Interim / Quarterly Rep…
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure ASA: Results for the third quarter of 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Report Q3 2022' and contains detailed financial statements, income statements, operational reviews, and management commentary for the third quarter of 2022. It provides substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). Q3 2022
2022-11-02 English
Photocure ASA: Results for the third quarter of 2022
Earnings Release Classification · 100% confidence The document explicitly states it contains "Results for the third quarter of 2022" and provides key financial metrics (revenues, EBITDA) for that period. It is a summary announcement of quarterly results, not the comprehensive report itself (which would be an IR). The text mentions that the "full financial report and presentation" are enclosed/will be published, and it details key highlights and management commentary. This strongly aligns with the definition of an Earnings Release (ER). The document is short and acts as the initial release of period results. Q3 2022
2022-11-02 English
Photocure ASA: Results for the third quarter of 2022
Earnings Release Classification · 99% confidence The document explicitly states it contains 'Results for the third quarter of 2022' and provides key financial metrics (revenues, EBITDA) for that period. This content structure is characteristic of an Earnings Release (ER) or an Interim/Quarterly Report (IR). Since the text summarizes the key financial highlights and mentions that the 'full financial report and presentation' will be published separately, it functions primarily as an initial announcement of results. The document is dated November 2, 2022, reporting on Q3 2022. This aligns perfectly with the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). It is not the comprehensive 'Interim Report' (IR) itself, as it directs the reader to the enclosed full report/presentation. Q3 2022
2022-11-02 English
Photocure ASA: Invitation to presentation of third quarter 2022 financial results
Report Publication Announcement Classification · 98% confidence The document is an invitation announcing the upcoming release of the third quarter 2022 financial results and the subsequent investor presentation/webcast scheduled for November 2, 2022. It explicitly states that the 'quarterly report and presentation will be published at 08:00 CEST' and invites users to the presentation. Since the document itself is an announcement about the publication of financial results and the associated presentation, and given its short length (1831 characters), it fits the definition of a Report Publication Announcement (RPA) rather than the full Interim Report (IR) or Earnings Release (ER) itself. It is announcing the release of those reports.
2022-10-25 English
Photocure ASA: Invitation to presentation of third quarter 2022 financial results
Report Publication Announcement Classification · 98% confidence The document explicitly states it is an 'Invitation to presentation of third quarter 2022 financial results'. It announces *when* the quarterly report and presentation will be published (08:00 CEST) and *when* the investor presentation/webcast will occur (14:00 CEST). Since the document itself is an announcement about the upcoming release and presentation of results, rather than the full results (IR) or the presentation slides (IP), it fits the definition of a Report Publication Announcement (RPA). The document length (1798 chars) is short, supporting the 'MENU VS MEAL' rule, indicating it is an announcement, not the full report.
2022-10-25 English
Major shareholder disclosure
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled "Standard form for notification of major holdings" and details changes in voting rights percentages (crossing thresholds) for a specific shareholder (Skandinaviska Enskilda Banken AB (publ)) concerning the issuer (Photocure ASA). This structure and content directly correspond to regulatory filings concerning significant changes in share ownership, which maps precisely to the Major Shareholding Notification category.
2022-10-10 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.